Bernhard E. Spiess
Net Worth

Last updated:

What is Bernhard E. Spiess net worth?

The estimated net worth of Mr. Bernhard E. Spiess is at least $10,926,396 as of 10 Dec 2021. He owns shares worth $269,884 as insider, has earned $8,014,762 from insider trading and has received compensation worth at least $2,641,750 in Castle Biosciences, Inc..

What is the salary of Bernhard E. Spiess?

Mr. Bernhard E. Spiess salary is $528,350 per year as Chief Bus. Officer in Castle Biosciences, Inc..

How old is Bernhard E. Spiess?

Mr. Bernhard E. Spiess is 65 years old, born in 1960.

What stocks does Bernhard E. Spiess currently own?

As insider, Mr. Bernhard E. Spiess owns shares in one company:

Company Title Shares Price per share Total value
Castle Biosciences, Inc. (CSTL) Chief Bus. Officer 13,562 $19.9 $269,884

What does Castle Biosciences, Inc. do?

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

CSTL logo
CSTL
Castle Biosciences, Inc.
$19.9

Bernhard E. Spiess insider trading

Castle Biosciences, Inc.

Mr. Bernhard E. Spiess has made 8 insider trades between 2020-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 40,000 units of CSTL stock on 1 Dec 2020. As of 10 Dec 2021 he still owns at least 13,562 units of CSTL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,500 N/A N/A
Option
Restricted Stock Units 1,500 N/A N/A
Sale
Common Stock 15,401 $76.22 $1,173,910
Option
Common Stock 15,401 $2.16 $33,189
Option
Stock option (right to buy) 15,401 $2.16 $33,189
Sale
Common Stock 8,989 $1.92 $17,259
Option
Stock option (right to buy) 8,989 $1.92 $17,259
Option
Common Stock 8,989 $1.92 $17,259
Sale
Common Stock 40,000 $49.97 $1,998,800
Sale
Common Stock 15,000 $49.8 $747,000
Sale
Common Stock 14,888 $49 $729,512
Sale
Common Stock 25,112 $48 $1,205,376
Sale
Common Stock 20,000 $45 $900,000
Sale
Common Stock 32,233 $38.56 $1,242,904
Option
Stock option (right to buy) 32,233 $1.92 $61,887
Option
Common Stock 32,233 $1.92 $61,887

Castle Biosciences key executives

Castle Biosciences, Inc. executives and other stock owners filed with the SEC: